AKT1 and colon adenocarcinoma: HOXD10 was inhibited in colon adenocarcinoma cells, thereby downregulating the RHOC/AKT/MAPK pathway to enhance apoptosis and restrain proliferation, migration, and invasion of colon cancer cells [47].